DGX

Quest Diagnostics Incorporated Healthcare - Diagnostics & Research Investor Relations →

NO
62.0% ABOVE
↑ Moving away Was 60.1% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $160.28
14-Week RSI 64
Rel. Volume (14w) This week's trading vs. the 14-week average 0.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.06

Quest Diagnostics Incorporated (DGX) closed at $259.60 as of 2026-11-13, trading 62.0% above its 200-week moving average of $160.28. The stock moved further from the line this week, up from 60.1% last week. The 14-week RSI sits at 64, indicating neutral momentum.

Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.06 ratio) is neutral — neither side is clearly dominating.

Over the past 1512 weeks of data, DGX has crossed below its 200-week moving average 19 times. On average, these episodes lasted 9 weeks. Historically, investors who bought DGX at the start of these episodes saw an average one-year return of +27.4%.

With a market cap of $28.6 billion, DGX is a large-cap stock. The company generates a free cash flow yield of 3.0%. Return on equity stands at 15.3%, a solid level. The stock trades at 3.7x book value.

Over the past 29.1 years, a hypothetical investment of $100 in DGX would have grown to $9051, compared to $1297 for the S&P 500. That represents an annualized return of 16.8% vs 9.2% for the index — confirming DGX as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 1.1% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: DGX vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After DGX Crosses Below the Line?

Across 19 historical episodes, buying DGX when it crossed below its 200-week moving average produced an average return of +26.9% after 12 months (median +25.0%), compared to +20.0% for the S&P 500 over the same periods. 84% of those episodes were profitable after one year. After 24 months, the average return was +107.4% vs +39.4% for the index.

Each line shows $100 invested at the moment DGX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices DGX would reach each dislocation threshold.

Current Bean Score -0.67σ
Current FCF Yield 4.81%
Baseline Yield 5.38%
Historical σ 0.27pp

Dislocation Price Levels

Prices where DGX's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$226.17Unusually cheap — analysis point
Value+1σ$237.64Cheap vs. own history
Fair Value+0σ$250.33Historical mean behavior
Expensive-1σ$264.45Expensive vs. own history
Deep Expensive-2σ$280.26Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-22$2.87$3.00+4.4%
2026-07-23$2.82$3.12+10.5%
2026-04-21$2.37$2.50+5.6%
2026-02-10$2.36$2.42+2.6%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from DGX's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation -2.61σ Dividend yield vs own 10-yr norm
Drawdown Score -0.64σ Distance from line vs own history
Sector-Relative -0.30σ Vs sector median this week
Buyback Acceleration -0.1pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 7th TTM buys / market cap, percentile of buyers
FCF Yield vs History -3.1pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-3.1pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

DGX has crossed below its 200-week MA 19 times with an average 1-year return of +27.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Nov 1997Apr 1998209.4%+9.6%+8951.2%
Aug 1998Nov 19981115.6%+54.7%+8397.7%
Dec 1998Dec 199821.4%+69.8%+8397.7%
Feb 2003Feb 200311.6%+72.8%+1439.0%
Jan 2008Jul 20082511.0%-4.2%+630.2%
Sep 2008Feb 20091821.6%+4.6%+608.7%
Feb 2009May 20091413.3%+13.2%+593.8%
Sep 2009Sep 200910.8%-4.7%+593.4%
May 2010Jun 201010.7%+13.9%+582.7%
Jun 2010Dec 20102513.0%+18.0%+593.3%
Aug 2011Oct 20111210.2%+18.2%+588.0%
Dec 2013Mar 2014147.0%+19.6%+521.8%
Dec 2018Jan 201975.0%+25.8%+256.2%
Mar 2019Mar 201912.4%+35.6%+258.6%
Apr 2019Apr 201910.9%+13.8%+250.8%
Mar 2020Apr 2020422.4%+70.2%+293.8%
Sep 2023Oct 202353.6%+26.7%+123.8%
Jan 2024Mar 202483.7%+33.2%+118.6%
Apr 2024Apr 202420.6%+30.2%+111.4%
Average9—+27.4%—

Frequently Asked Questions

Is DGX below its 200-week moving average?

No. Quest Diagnostics Incorporated (DGX) is currently 62.0% above its 200-week moving average of $160.28. It would need to fall to $160.28 to cross below the line.

What is DGX's 200-week moving average price?

Quest Diagnostics Incorporated's 200-week moving average is $160.28 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when DGX drops below its 200-week moving average?

DGX has crossed below its 200-week moving average 19 times in our data. On average, buying at that moment produced a one-year return of +27.4%. These dips have historically been decent entry points. These episodes lasted 9 weeks on average.

Is DGX a good value right now?

Here's what our data says about DGX as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 64. Free cash flow yield is 3.0%. Return on equity is 15.3%. Price-to-book is 3.7x. This is not a buy or sell recommendation — always do your own research.

How does DGX compare to the S&P 500?

Over the past 29.1 years, $100 invested in DGX would have grown to $9051, compared to $1297 for the S&P 500. That's 16.8% annualized vs 9.2% for the index. DGX has outperformed the broader market over this period.

Does DGX pay a dividend?

Yes. Quest Diagnostics Incorporated currently pays a dividend yield of 133.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13